Pascolizumab (SB 240683) is a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Pascolizumab (SB 240683) is a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Investigated for use/treatment in asthma.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.